From the Guardian · September 18, 2024
All 23andMe board members but CEO resign over no adequate buyout offers
Seven of eight members of 23andMe's board resigned, leaving the CEO, ████████, as the only remaining member. The independent directors said they were quitting after not receiving a satisfactory buyout offer from ████████, the company's co-founder and CEO. ████████ had been trying to take the company private since earlier in the year, proposing to acquire all outstanding shares she didn't already control for $0.40 a share. She controls 49% of voting shares. 23andMe, best known for its saliva-based test kits offering users a glimpse into their genetic ancestry, went public in 2021 but has never turned a profit.